$40.77
-1.15-2.74%
Last update: Dec 16, 12:29 PM
Comments
Loading...
Dianthus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:DNTH | Benzinga
Dianthus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 10
EPS Estimate
$-1.010
Quarterly Revenue Estimate
$446.85K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$3.08M
Analyze the earnings history of Dianthus Therapeutics using advanced sorting and filters.
Dianthus Therapeutics (DNTH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $-0.97 | $-0.88 | -10.2 % |
| Q2 | 2025-08-07 | $-0.88 | $-0.86 | -2.33 % |
| Q1 | 2025-05-12 | $-0.82 | $-0.71 | -15.5 % |
| Q4 | 2025-03-11 | $-0.81 | $-0.85 | 4.71 % |
Dianthus Therapeutics (DNTH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $396.00K | $578.18K | -31.5 % |
| Q2 | 2025-08-07 | $193.00K | $1.01M | -81.0 % |
| Q1 | 2025-05-12 | $1.16M | $806.90K | 44.1 % |
| Q4 | 2025-03-11 | $1.33M | $859.70K | 54.1 % |
FAQ
When is Dianthus Therapeutics (NASDAQ:DNTH) reporting earnings?
Dianthus Therapeutics (DNTH) is scheduled to report earnings on March 10, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
What were the latest earnings per share (EPS) for Dianthus Therapeutics (NASDAQ:DNTH)?
The Actual EPS was $-0.97, which missed the estimate of $-0.88.
What were Dianthus Therapeutics’s (NASDAQ:DNTH) revenues?
The Actual Revenue was $396K, which missed the estimate of $578.2K.
Browse earnings estimates, EPS, and revenue on all stocks.
